Clinical Trials Browser

Phase NA × pembrolizumab × 30 days × Clear all

NCT07629700 2026-06-05

ENDEAVOR

Phase NA Not yet recruiting

Carcinoma, Transitional Cell, Peripheral Nervous System Diseases

NCT02194738 2026-05-29

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Phase NA Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms